ES2333863T3 - Formulaciones de medios de contraste para mejorar la tolerancia biologica. - Google Patents

Formulaciones de medios de contraste para mejorar la tolerancia biologica. Download PDF

Info

Publication number
ES2333863T3
ES2333863T3 ES03786628T ES03786628T ES2333863T3 ES 2333863 T3 ES2333863 T3 ES 2333863T3 ES 03786628 T ES03786628 T ES 03786628T ES 03786628 T ES03786628 T ES 03786628T ES 2333863 T3 ES2333863 T3 ES 2333863T3
Authority
ES
Spain
Prior art keywords
formulation
tris
dimeric
acid
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03786628T
Other languages
English (en)
Spanish (es)
Inventor
Milos Sovak
Allen L. Seligson
Ronald C. Terry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biophysica Foundation
Original Assignee
Biophysica Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophysica Foundation filed Critical Biophysica Foundation
Application granted granted Critical
Publication of ES2333863T3 publication Critical patent/ES2333863T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES03786628T 2002-12-12 2003-11-07 Formulaciones de medios de contraste para mejorar la tolerancia biologica. Expired - Lifetime ES2333863T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43287902P 2002-12-12 2002-12-12
US432879P 2002-12-12
US10/701,586 US7250153B2 (en) 2002-12-12 2003-11-05 Contrast media formulations having improved biological tolerance
US701586 2003-11-05

Publications (1)

Publication Number Publication Date
ES2333863T3 true ES2333863T3 (es) 2010-03-02

Family

ID=34107426

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03786628T Expired - Lifetime ES2333863T3 (es) 2002-12-12 2003-11-07 Formulaciones de medios de contraste para mejorar la tolerancia biologica.

Country Status (18)

Country Link
US (1) US7250153B2 (enExample)
EP (1) EP1575621B1 (enExample)
JP (1) JP2006509841A (enExample)
KR (1) KR101067159B1 (enExample)
CN (1) CN1738651A (enExample)
AT (1) ATE447416T1 (enExample)
AU (1) AU2003295442B2 (enExample)
CA (1) CA2509035C (enExample)
CY (1) CY1110105T1 (enExample)
DE (1) DE60329939D1 (enExample)
DK (1) DK1575621T3 (enExample)
ES (1) ES2333863T3 (enExample)
IL (1) IL169119A (enExample)
NO (1) NO332350B1 (enExample)
NZ (1) NZ541139A (enExample)
PT (1) PT1575621E (enExample)
SI (1) SI1575621T1 (enExample)
WO (1) WO2004054637A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070015517A (ko) * 2004-03-11 2007-02-05 말린크로트, 인코포레이티드 요오드화된 단량체 및 이량체의 혼합물을 포함하는 ｘ-선조영제 제형
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
WO2009091758A1 (en) 2008-01-14 2009-07-23 Mallinckrodt Inc. Process for the preparation of iosimenol
RU2012138280A (ru) * 2010-03-23 2014-04-27 ДжиИ Хелткер АС Получение стабилизированной диагностической композиции для рентгеновского исследования

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR222337A1 (es) * 1978-07-04 1981-05-15 Nyegaard & Co As Procedimiento para preparar una solucion esteril inyectable fisiologicamente aceptable de un agente de contraste de rayos x
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
KR19990022943A (ko) * 1995-06-16 1999-03-25 밀로스 소박 비이온성 조영제로서의 포르밀 유도체
DE19648650C2 (de) 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung

Also Published As

Publication number Publication date
SI1575621T1 (sl) 2010-01-29
CY1110105T1 (el) 2015-01-14
US20050025711A1 (en) 2005-02-03
NO20053343D0 (no) 2005-07-08
AU2003295442A1 (en) 2004-07-09
NO20053343L (no) 2005-09-08
WO2004054637A3 (en) 2004-09-16
CA2509035C (en) 2011-07-19
WO2004054637A2 (en) 2004-07-01
US7250153B2 (en) 2007-07-31
IL169119A0 (en) 2007-07-04
PT1575621E (pt) 2009-11-13
CN1738651A (zh) 2006-02-22
CA2509035A1 (en) 2004-07-01
EP1575621B1 (en) 2009-11-04
EP1575621A4 (en) 2008-11-26
KR20050088312A (ko) 2005-09-05
ATE447416T1 (de) 2009-11-15
DE60329939D1 (de) 2009-12-17
KR101067159B1 (ko) 2011-09-22
NO332350B1 (no) 2012-09-03
EP1575621A2 (en) 2005-09-21
JP2006509841A (ja) 2006-03-23
DK1575621T3 (da) 2009-12-14
AU2003295442B2 (en) 2008-11-06
IL169119A (en) 2010-06-16
NZ541139A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
CN107810000B (zh) 来氟米林的可注射药物组合物
ES2374633T3 (es) Formulación de contraste por rayos x que comprende una mezcla de monómero y dímero yodado.
ES2333863T3 (es) Formulaciones de medios de contraste para mejorar la tolerancia biologica.
ES2398291T3 (es) Agentes de contraste
EP1792894B1 (en) Contrast agents
AU2012357059B2 (en) Stabilization of X-ray diagnostic composition
EP1798219A1 (en) Contrast agents
US7662859B2 (en) Contrast agents
GB2465663A (en) X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid
CZ291597A3 (cs) Rentgenové kontrastní prostředky pro počítačovou tomografii a urografii
KR20150014526A (ko) 고농도의 조영제를 포함하여 높은 조영 증강 효과를 나타내는 조영제 조성물